Table 2.

Summary of Cancer and Stroke Types (N=15)

Cancer Diagnosis until Stroke (months)	After Stroke until Death (days)	Cancer Type	Outcome	WBC Count (103/mm3)	Platelet Count (103/mm3)	Abnormal Coagulation	Cause of Stroke
Hemorrhagic Stroke
IP	1	Pre-T leukemia	Dead	840	54	Yes	Leukostasis, Thrombocytopenia, Coagulopathy/DIC
IP	1	AML	Dead	52.5	28	Yes	Hyperleukocytosis, Thrombocytopenia, Coagulopathy/DIC
5	5	Rhabdomyosar coma with secondary M5 AML	Dead	10.2	39	No	Thrombocytopenia
7	1	Acute T-cell lymphoblastic leukemia	Dead	487	70	Yes	Leukostasis, Coagulopathy/DIC
18	470	T-cell lymphoblastic lymphoma	Dead	48	14	N/A	Thrombocytopenia
19	3	Brainstem glioma	Dead	4.4	30	No	Thrombocytopenia
58	1	Pre-B ALL	Dead	1.1	31	Yes	Thrombocytopenia Coagulopathy/DIC
Hemorrhagic and Ischemic Stroke
IP	325	Anaplastic astrocytoma	Dead	22	320	No	Ischemic injury s/p mass effect; second stroke was idiopathic hemorrhage
Ischemic Stroke
IP	34	High grade thalamic glioma	Dead	26	311	Yes	Ischemic injury s/p tumor mass effect
IP	409	Grade 4 glioma, cerebellopontine angle	Dead	17	237	No	Ischemic injury s/p tumor mass effect
58	N/A	AML with CNS relapse	Alive	40	369	No	CNS relapse of leukemia presenting as diffuse ischemic stroke
43	34	Recurrent anaplastic astrocytoma with secondary AML	Dead	4.5	8	Yes	Ischemic stroke due to radiation induced vasculopathy
CSVT
1	N/A	Pre-B ALL	Alive	1.2	90	No	CSVT after L-asparaginase with ischemic venous infarction
IP	256	Burkitt lymphoma	Dead	11.5	207	No	CSVT due to tumoral infiltrative process
10	181	ALL	Dead	5.9	167	No	CSVT after L-asparaginase with ischemic venous infarction

Abbreviations:

ALL = acute lymphoblastic leukemia

AML = acute myelogenous leukemia

CNS = central nervous system

CSVT = cerebral sinovenous thrombosis

DIC = disseminated intravascular coagulation

IP = initial presentation

N/A = not applicable

s/p = suspected

WBC = white blood cell